WO2001013881A1 - Produits cosmetiques - Google Patents
Produits cosmetiques Download PDFInfo
- Publication number
- WO2001013881A1 WO2001013881A1 PCT/JP2000/005634 JP0005634W WO0113881A1 WO 2001013881 A1 WO2001013881 A1 WO 2001013881A1 JP 0005634 W JP0005634 W JP 0005634W WO 0113881 A1 WO0113881 A1 WO 0113881A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- carbon atoms
- group
- terpene
- skin
- hydrogen atom
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
Definitions
- the present invention relates to a cosmetic having a high effect of improving rough and rough skin and an effect of improving skin quality such as dry skin and sensitive skin.
- ceramide one of the stratum corneum intercellular lipids, plays an important role in the moisture retention and barrier function of the skin.
- the stratum corneum of people with dry or sensitive skin It is reported that the ceramide content is low.
- it has been attempted to improve the skin function by applying a skin external preparation containing a natural ceramide, a ceramide-like substance, and a phospholipid to compensate for the reduced ceramide in the stratum corneum Japanese Patent Application Laid-open No. 62-228048, JP-A-63-216812, JP-A-3-66604, JP-A-3-193754, JP-A-4-282304, etc.
- sesquiterpene compounds such as guaiol-cedrol have a melanin production inhibitory action, and skin external preparations containing the same are also known (JP-A-10-36246, JP-A-10-36247).
- compositions for external use on the skin comprising a physiologically active substance, sesquiterpenes and a water-soluble polyhydric alcohol (JP-A-6-128120) is also known.
- An object of the present invention is to provide a cosmetic that is highly effective in improving rough skin and rough skin even on dry skin and sensitive skin. Disclosure of the invention
- the present inventors have found that the use of a combination of a horny layer-containing lipid or a similar substance thereof and a terpene-based component results in less rough and rough skin even on dry or sensitive skin than when each of them is used alone. It has been found that the effect of improvement is dramatically improved, and that a cosmetic excellent in the effect of improving skin quality can be obtained.
- the present invention provides a cosmetic containing one or more selected from stratum corneum-containing lipids and similar substances, and a terpene-based component excluding control.
- the present invention provides a cosmetic composition
- a cosmetic composition comprising at least one of 0.01 to 60% by weight selected from lipids containing the stratum corneum and a substance similar thereto, and 0.05 to 20% by weight of a terpene component excluding menthol.
- FIG. 1 is a diagram illustrating the structure of natural ceramide. BEST MODE FOR CARRYING OUT THE INVENTION
- Examples of the lipid containing the stratum corneum used in the present invention include natural ceramides, ceramide-like substances, steroids, fatty acid esters of steroids, intercellular lipids such as fatty acids and triglycerides, and celeb mouth side-phospholipids and the like. Is mentioned. Of these, natural ceramides, ceramide-like substances, phospholipids, and fatty acid esters of steroids are preferred. Known natural ceramides exist between human stratum corneum cells.
- the ceramide-like substance is represented by, for example, the following general formulas (1) to (4), which are described in JP-A-63-216812 (general formula (1)) and JP-A-8-319263 (general formula (2) )), JP-A-3-193754 (general formula (3)), JP-A-4-282304 (general formula (4)) and the like.
- R ′ represents a hydrocarbon group having 10 to 26 carbon atoms, a hydrocarbon group having 9 to 25 carbon atoms, and n represents a number of 2 to 6)
- R! Is preferably a linear or branched alkyl group or an alkenyl group having 10 to 26 carbon atoms, and particularly preferably an alkyl group having 10 to 18 carbon atoms.
- R 2 a linear or branched alkyl group or alkenyl group having 9 to 25 carbon atoms is preferable, and an alkyl group having 9 to 21 carbon atoms is particularly preferable.
- R 3 and R 4 are the same or different and each represent an optionally hydroxylated hydrocarbon group having 1 to 40 carbon atoms
- R 5 represents an alkylene group having 1 to 6 carbon atoms or a single bond
- R 6 represents a hydrogen atom, an alkoxy group having 1 to 12 carbon atoms or a 2,3-dihydroxypropyloxy group, provided that when R 5 is a single bond, R 6 is a hydrogen atom.
- R 3 is a linear or branched alkyl group having 8 to 26 carbon atoms or an alkyl group.
- a kenyl group is preferred, and an alkyl group having 12 to 22 carbon atoms is particularly preferred.
- R 4 a linear or branched alkyl group or alkenyl group having 9 to 25 carbon atoms is preferable, and an alkyl group having 11 to 21 carbon atoms is particularly preferable.
- R 5 a linear or branched alkylene group having 1 to 6 carbon atoms is preferable, and one having 1 to 3 carbon atoms is particularly preferable.
- R 6 is preferably a hydrogen atom, a linear or branched alkoxy group having 1 to 8 carbon atoms, or a 2,3-dihydroxypropyloxy group.
- R represents an alkyl group or an alkenyl group having 1 1-2 1 carbon atoms
- R s represents a hydrocarbon group having a carbon number of 3-30
- R is preferably an alkyl group having 13 to 17 carbon atoms
- R 8 is preferably a linear or branched alkyl or alkenyl group having 8 to 24 carbon atoms.
- CR 9 is an aliphatic hydrocarbon group having 1 to 49 carbon atoms which may be hydroxylated, phosphorylated or sulfated, or a sub-substituent- (C a H b ) —0—Y (Y is a hydrogen atom or formula
- ie 2 ' is hydrogen atom or sub-substituent
- X ′ X 2 and X 3 each represent a hydrogen atom or an optionally hydroxylated alkyl group having 15 carbon atoms, c represents a number of 04, d represents 0 or 1, and R represents And I and m represent 0 or 1, and when R 9 has 949 carbon atoms, 1 m is 1 or 2.
- R 9 is preferably a straight-chain or branched-chain alkyl group or alkenyl group having 632 carbon atoms, and particularly preferably an alkyl group having 102 carbon atoms.
- R 1Q a linear or branched alkyl group or alkenyl group having 822 carbon atoms is preferable, and an alkyl group having 1020 carbon atoms is particularly preferable.
- R ′ 1 is preferably a hydrogen atom, and R 12 is preferably a hydroxyethyl group.
- a ceramide-like substance represented by the general formula (1) or (2) is particularly preferable.
- Examples of the phospholipid include those described in JP-A-3-66604 and the like, and include those represented by the following general formula (5). CH, one O one R 13
- R "and R" is one C—C 17 H 35 or one C—C 15 H 31
- R '5 represents a hydroxylated hydrocarbon group which may be substituted having 1 to 2 5 carbon atoms
- the cholesterol fatty acid ester represented by is preferable.
- stratum corneum-containing lipids or similar substances may be used, and the total composition may contain 0.01 to 60% by weight, particularly 0.05 to 40% by weight, and more preferably 0.1 to 2% by weight. It is preferable to contain 0% by weight because the feeling in use is excellent.
- Terpene-based components include monoterpenes, sesquiterpenes, diterpenes, etc.
- Terpene-based hydrocarbons terpene-based alcohols other than terpene-based alcohols, terpene-based aldehydes, terpene-based ketones, etc. Hydrocarbons and sesquiterpene alcohols are more preferred.
- Terpene-based hydrocarbons include ⁇ -pinene, 3-pinene, camphene, limonene, myrcene, and 3-force lyophylene;
- terpene-based alcohols include linalool, geraniol, nerol, citronellol, lavandulol, myrsenol, ⁇ —Tervineol, borneol, nopol, isobornylcyclohexanol, fuarnetur, nerolidol, sanyu roll, cedrol, guayol, pettivelol, pachiyuri alcohol, etc.
- huarnesol, sanyu roll, cedrol, guayol, vetiverol, and nourich alcohol are preferred.
- a terpene-based component that is substantially odorless, such as cedrol is advantageous in that it has a high degree of freedom in blending into cosmetics because it does not affect the palatability of aroma.
- plant extracts, steam distillates or pressed products containing these terpene-based components can be used, which is preferable.
- Such plants include, for example, Seda Wood, Pachi Lily, Sandalwood, Petipa, Ginger, Cumin, Mill, Pepper, Rosemary, Nora, Jasmine, Power Nokoso, Honeysuckle, Thyme, Tea, Guaiac Wood, etc., and in particular, Cedarwood, Pachiyuri, Sandalwood, Pettibur, Ginger, Pepper, Rosemary, Rose, Honeysuckle, Guayakwood are preferred, and Cedarwood, Pachiyuri, Sandalwood, Pettibur, Guayakwood are preferred. Is more preferred.
- These plants may be extracted, steam distilled, squeezed, etc. by a conventional method.Furthermore, these fractions can be fractionated and used, or refined essential oil can be used, or derivatized by a reaction such as acetylation. It can also be used.
- One or more terpene-based components can be used. It is preferable to use a plant extract containing two or more terpene-based components, because the effect of improving skin quality is further enhanced.
- the terpene-based component accounts for at least 0.05% by weight, especially 0.05 to 20% by weight, more preferably 0.1 to 20% by weight, further 1.0 to 10% by weight in the total composition. It is preferable to include such a content from the viewpoint of the effect of improving rough skin and dry skin on dry skin and sensitive skin.
- the cosmetic of the present invention includes, in addition to the above-mentioned components, components used in ordinary cosmetics, for example, surfactants, oils, amino acids, other humectants, powders, ultraviolet absorbers, gelling agents, Inflammatory agents, antioxidants, pH regulators, menthol and other fragrances can be added as appropriate.
- components used in ordinary cosmetics for example, surfactants, oils, amino acids, other humectants, powders, ultraviolet absorbers, gelling agents, Inflammatory agents, antioxidants, pH regulators, menthol and other fragrances can be added as appropriate.
- the cosmetic of the present invention can be produced by a usual method, and can be in any dosage form such as a solubilizing system, an emulsifying system, a powder dispersing solubilizing system, a powder dispersing emulsifying system, a powder dispersing oil and the like.
- a skin care cosmetic such as a lotion, an emulsion, a cream, a serum, a cosmetic oil, and a makeup cosmetic such as a foundation, a powder, a lipstick, a blusher, an eye shadow, a nail enamel, and the like.
- Emulsified cosmetics having the compositions shown in Tables 1 and 2 were produced by a conventional method, and the effects of improving skin roughness / bulkiness and improving skin quality were evaluated. The results are shown in Tables 1 and 2. (Evaluation method)
- ⁇ Skin roughness and rough skin are less likely to occur than before use.
- a lotion having the following composition was produced by a conventional method.
- Example 3 (OZW type emulsion) An OZW emulsion having the following composition was produced by a conventional method.
- a WZ ⁇ type cream having the following composition was produced by a conventional method.
- Polyoxyalkylene modified silicone 5.0 1,3-butylene glycol 6.0
- Each of the cosmetics obtained in Examples 2 to 4 has a high effect of improving rough skin and rough skin, and has an effect of improving skin quality such as dry skin and sensitive skin.
- the cosmetics of this invention are highly effective in improving rough skin and rough skin, and have the effect of improving the skin quality of dry skin and sensitive skin.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001518020A JP4523747B2 (ja) | 1999-08-24 | 2000-08-23 | 化粧料 |
EP00954920A EP1206932A4 (en) | 1999-08-24 | 2000-08-23 | COSMETIC PRODUCTS |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11/236826 | 1999-08-24 | ||
JP23682699 | 1999-08-24 | ||
JP26731799 | 1999-09-21 | ||
JP11/267317 | 1999-09-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001013881A1 true WO2001013881A1 (fr) | 2001-03-01 |
Family
ID=26532885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2000/005634 WO2001013881A1 (fr) | 1999-08-24 | 2000-08-23 | Produits cosmetiques |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1206932A4 (ja) |
JP (1) | JP4523747B2 (ja) |
WO (1) | WO2001013881A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1031348A2 (en) * | 1999-02-22 | 2000-08-30 | Kao Corporation | Interleukin-4 production inhibitors |
WO2003028673A1 (fr) * | 2001-09-11 | 2003-04-10 | Kao Corporation | Preparation cosmetique |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4077125B2 (ja) * | 1999-10-22 | 2008-04-16 | 花王株式会社 | 化粧料 |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06128137A (ja) * | 1992-10-13 | 1994-05-10 | Pola Chem Ind Inc | 化粧料 |
JPH06128120A (ja) * | 1992-10-13 | 1994-05-10 | Kanebo Ltd | 皮膚外用組成物 |
JPH07206879A (ja) * | 1993-12-27 | 1995-08-08 | Roussel Uclaf | 活性分子の媒介体としての燐脂質、それらの製造法及びそれらの化粧用又は皮膚科用組成物への使用 |
JPH07309710A (ja) * | 1994-05-20 | 1995-11-28 | Eisai Co Ltd | 外用基剤 |
WO1997014401A1 (en) * | 1995-10-16 | 1997-04-24 | Kao Corporation | Skin and hair cosmetic compositions |
JPH09241144A (ja) * | 1996-03-04 | 1997-09-16 | Lion Corp | セラミド誘導体およびそれを含有する化粧料 |
JPH09241143A (ja) * | 1996-03-04 | 1997-09-16 | Lion Corp | セラミド誘導体およびそれを含有する化粧料 |
JPH1036246A (ja) * | 1996-07-24 | 1998-02-10 | Pola Chem Ind Inc | メラニン産生抑制剤及び皮膚外用剤 |
JPH10167957A (ja) * | 1996-12-09 | 1998-06-23 | Kao Corp | 細胞間接着抑制剤 |
US5776480A (en) * | 1994-12-14 | 1998-07-07 | L'oreal | Cosmetic or dermatological composition containing a mixture of ceramides for moisturizing the skin |
JPH11139924A (ja) * | 1997-11-10 | 1999-05-25 | Kao Corp | 化粧料 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6133129A (ja) * | 1984-07-25 | 1986-02-17 | Nitto Electric Ind Co Ltd | 基剤組成物および外用医薬組成物 |
JPH01186824A (ja) * | 1988-01-19 | 1989-07-26 | Horiuchiitarou Shoten:Kk | 外皮投与用組成物及び経皮吸収を促進する方法 |
JPH0363233A (ja) * | 1989-07-31 | 1991-03-19 | Kiyuukiyuu Yakuhin Kogyo Kk | 経皮吸収促進物質 |
JPH04217920A (ja) * | 1990-03-30 | 1992-08-07 | Morimoto Kazutoshi | 経皮吸収組成物 |
JPH0648962A (ja) * | 1991-10-24 | 1994-02-22 | Kazutoshi Morimoto | 経皮吸収製剤用組成物 |
US5599546A (en) * | 1992-06-16 | 1997-02-04 | Klein; Marvin E. | Medicinal facial mask |
JP3488479B2 (ja) * | 1992-09-01 | 2004-01-19 | 花王株式会社 | 浴用剤組成物 |
FR2702654B1 (fr) * | 1993-03-18 | 1995-05-05 | Danielle Morazzani | Produit cosmétique destiné à raffermir l'épiderme. |
JPH0733637A (ja) * | 1993-07-19 | 1995-02-03 | Kanebo Ltd | 皮膚化粧料 |
CN1098621A (zh) * | 1993-08-10 | 1995-02-15 | 李述慎 | 止痒护肤沙 |
JP3207996B2 (ja) * | 1994-01-11 | 2001-09-10 | カネボウ株式会社 | 日焼け止め化粧料 |
JPH08268859A (ja) * | 1995-04-03 | 1996-10-15 | Kao Corp | シワ予防・改善化粧料 |
JP3924017B2 (ja) * | 1995-12-25 | 2007-06-06 | 埼玉第一製薬株式会社 | 外用医薬組成物 |
JPH1036247A (ja) * | 1996-07-24 | 1998-02-10 | Pola Chem Ind Inc | メラニン産生抑制剤及び皮膚外用剤 |
JPH10114648A (ja) * | 1996-10-11 | 1998-05-06 | Kao Corp | 皮膚外用組成物 |
AUPO316796A0 (en) * | 1996-10-23 | 1996-11-14 | Hood, John James David | Essential oil |
CN1066041C (zh) * | 1997-05-26 | 2001-05-23 | 朱珊引 | 抗炎、止痒、祛痱护扶霜 |
CN1062171C (zh) * | 1997-07-10 | 2001-02-21 | 中山大学 | 广藿香油在制备皮肤抗菌剂中的应用 |
DE19754282A1 (de) * | 1997-12-08 | 1999-06-10 | Henkel Kgaa | Kosmetische Mittel |
JP4194196B2 (ja) * | 1999-02-22 | 2008-12-10 | 花王株式会社 | 浴用剤組成物 |
-
2000
- 2000-08-23 WO PCT/JP2000/005634 patent/WO2001013881A1/ja not_active Application Discontinuation
- 2000-08-23 JP JP2001518020A patent/JP4523747B2/ja not_active Expired - Fee Related
- 2000-08-23 EP EP00954920A patent/EP1206932A4/en not_active Withdrawn
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06128137A (ja) * | 1992-10-13 | 1994-05-10 | Pola Chem Ind Inc | 化粧料 |
JPH06128120A (ja) * | 1992-10-13 | 1994-05-10 | Kanebo Ltd | 皮膚外用組成物 |
JPH07206879A (ja) * | 1993-12-27 | 1995-08-08 | Roussel Uclaf | 活性分子の媒介体としての燐脂質、それらの製造法及びそれらの化粧用又は皮膚科用組成物への使用 |
JPH07309710A (ja) * | 1994-05-20 | 1995-11-28 | Eisai Co Ltd | 外用基剤 |
US5776480A (en) * | 1994-12-14 | 1998-07-07 | L'oreal | Cosmetic or dermatological composition containing a mixture of ceramides for moisturizing the skin |
WO1997014401A1 (en) * | 1995-10-16 | 1997-04-24 | Kao Corporation | Skin and hair cosmetic compositions |
JPH09241144A (ja) * | 1996-03-04 | 1997-09-16 | Lion Corp | セラミド誘導体およびそれを含有する化粧料 |
JPH09241143A (ja) * | 1996-03-04 | 1997-09-16 | Lion Corp | セラミド誘導体およびそれを含有する化粧料 |
JPH1036246A (ja) * | 1996-07-24 | 1998-02-10 | Pola Chem Ind Inc | メラニン産生抑制剤及び皮膚外用剤 |
JPH10167957A (ja) * | 1996-12-09 | 1998-06-23 | Kao Corp | 細胞間接着抑制剤 |
JPH11139924A (ja) * | 1997-11-10 | 1999-05-25 | Kao Corp | 化粧料 |
Non-Patent Citations (2)
Title |
---|
GENJI IMOKAWA: "Kakushitsu Saiboukan Shishitsu no Kinou To sono Ouyou", FRAHRANCE JOURNAL, vol. 18, no. 4, April 1990 (1990-04-01), pages 26 - 34, XP002934245 * |
See also references of EP1206932A4 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1031348A2 (en) * | 1999-02-22 | 2000-08-30 | Kao Corporation | Interleukin-4 production inhibitors |
EP1031348B1 (en) * | 1999-02-22 | 2007-07-25 | Kao Corporation | Interleukin-4 production inhibitors |
WO2003028673A1 (fr) * | 2001-09-11 | 2003-04-10 | Kao Corporation | Preparation cosmetique |
Also Published As
Publication number | Publication date |
---|---|
EP1206932A4 (en) | 2005-09-14 |
JP4523747B2 (ja) | 2010-08-11 |
EP1206932A1 (en) | 2002-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3503884B2 (ja) | 化粧料 | |
AU9742501A (en) | Method for reducing the appearance of dark circles under the eyes | |
US20100173027A1 (en) | O/w emulsion for hand care | |
US20100323040A1 (en) | Cosmetic composition for topical use comprising wasabi | |
JP5236867B2 (ja) | 固形化粧料 | |
JP3383496B2 (ja) | 液晶型エマルションの製造方法および該製造方法によって得られる液晶型エマルション組成物 | |
JPH11130656A (ja) | 脂肪蓄積抑制剤及びそれを含有する皮膚外用剤 | |
JP2002161027A (ja) | 炎症および紅斑の減少方法および組成物 | |
JPH08208420A (ja) | 付着を引き起こす脂質系を含有する化粧乳濁液 | |
JP4523747B2 (ja) | 化粧料 | |
JP3503834B2 (ja) | 化粧料 | |
JP3315013B2 (ja) | 皮膚化粧料 | |
JP2641003B2 (ja) | 皮膚外用剤 | |
JPH0450288B2 (ja) | ||
JP3513861B2 (ja) | 皮膚外用剤 | |
JP2003183148A (ja) | 皮膚外用剤組成物 | |
JP3526330B2 (ja) | 皮膚化粧料 | |
JPH07277943A (ja) | 皮膚化粧料 | |
JP2002179549A (ja) | 皮膚外用剤 | |
KR102365222B1 (ko) | 알부틴과 쪽 잎 및 자작나무 껍질 추출물을 함유하는 저자극성 피부 미백용 화장료 조성물 | |
JPH03161416A (ja) | 皮膚化粧料 | |
JP3481775B2 (ja) | ミクロエマルションおよびこれを配合してなる化粧料 | |
KR102365223B1 (ko) | 알부틴과 쪽 잎 및 유채 전초 추출물을 함유하는 저자극성 피부 미백용 화장료 조성물 | |
JP3378784B2 (ja) | 化粧料 | |
JP2791145B2 (ja) | 皮膚化粧料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): DE FR GB |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2001 518020 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000954920 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10049640 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2000954920 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000954920 Country of ref document: EP |